A nomogram to predict the prognosis of advanced soft tissue sarcoma patients treated with anlotinib: A real-world population-based study.

被引：0
|
作者：
Bin Wang
Liu, Jie
Zhang, Ren Shu
Jiang, Yu
机构：
[1] Sichuan Univ, West China Hosp, Dept Med Oncol, Ctr Canc, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23550
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Angiogenesis inhibitors and cardiovascular outcomes in cancer: Real-world, population-based, matched cohort study.
    Krishnan, Arunkumar
    Mukherjee, Diptasree
    Alqahtani, Saleh A.
    Walsh, Declan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] PROGNOSIS FOR SOFT-TISSUE SARCOMA IN THE LOCOMOTOR SYSTEM - A RETROSPECTIVE POPULATION-BASED FOLLOW-UP-STUDY OF 237 PATIENTS
    RYDHOLM, A
    BERG, NO
    GULLBERG, B
    PERSSON, BM
    THORNGREN, KG
    ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1984, 92 (05): : 375 - 386
  • [33] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN THE UNITED KINGDOM
    Mytelka, D. S.
    Lorenzo, M.
    Stafkey-Mailey, D.
    D'yachkova, Y.
    Nagar, S. P.
    Candrilli, S. D.
    Kaye, J. A.
    VALUE IN HEALTH, 2016, 19 (07) : A751 - A751
  • [34] Efficacy and safety of anlotinib with PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma: A real-world study.
    Chen, Kehe
    Huang, Xianshi
    Yu, Lei
    Lu, Jianxun
    Huang, Fei
    Wang, Zhiguang
    Wei, Yan
    Hou, Encun
    Luo, Min
    Huang, Shiqing
    Hu, Hongbo
    Ou, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 583 - 583
  • [35] Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients
    Fernebro, J.
    Bladstrom, A.
    Rydholm, A.
    Gustafson, P.
    Olsson, H.
    Engellau, J.
    Nilbert, M.
    BRITISH JOURNAL OF CANCER, 2006, 95 (08) : 986 - 990
  • [36] Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients
    J Fernebro
    A Bladström
    A Rydholm
    P Gustafson
    H Olsson
    J Engellau
    M Nilbert
    British Journal of Cancer, 2006, 95 : 986 - 990
  • [37] Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study
    Zhang, Song
    Wang, Xin
    Gu, Hao
    Liu, Jun-Qi
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1715 - 1727
  • [38] Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma Data of real-world utilization in Austria
    Seeber, Andreas
    Weiss, Lukas
    Romeder, Franz
    Szkandera, Joanna
    Kuehr, Thomas
    Kostner, Susanne
    Pichler, Petra
    Jaeger, Thomas
    Kocher, Florian
    Greil, Richard
    Brodowicz, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 21 - 25
  • [39] A real-world, population-based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer
    Abdel-Rahman, Omar
    Xu, Yuan
    Tang, Patricia A.
    Lee-Ying, Richard M.
    Cheung, Winson Y.
    CANCER MEDICINE, 2018, 7 (12): : 6385 - 6392
  • [40] Efficacy and safety of eribulin in the treatment of advanced adult soft tissue sarcoma (STS): First real-world data in Chinese population.
    Guo, Xi
    Zhou, Yuhong
    Zhuang, Rongyuan
    You, Yang
    Zhang, Chenlu
    Wang, Zhiming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345